🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

514 results for “Vir” Clear

  1. A study to learn how different amounts of the study medicine called PF-07941944 are tolerated in the body of healthy adults.

    Pfizer Australia Pty Ltd

    RSV (Respiratory Syncytial Virus)

    phase 1 other active

    1 trial

  2. A study to learn more about how BAY3283142 moves into, through, and out of the body of healthy participants when taken together with atazanavir and to assess the proportion of BAY3283142 that reaches the blood when taken by mouth.

    Bayer AG

    Chronic kidney disease

    phase 1 other active

    1 trial

  3. ABI-6250

    ASSEMBLY BIOSCIENCES, INC.

    Hepatitis Delta Virus

    phase 1 small molecule completed

    1 trial

  4. ATAFENOVIR 200 MG KAPSUL

    BRIGHT MINDS BIOSCIENCES INC.

    Bioequivalence

    phase 1 small molecule active

    1 trial

  5. AVI-4020 Injection

    Sarepta Therapeutics

    West Nile Virus

    phase 1 small molecule completed

    1 trial

  6. Ad5-EBOV

    Jian Li

    Ebola Virus Disease

    phase 1 mab completed

    1 trial

  7. AdV-tk + valacyclovir

    Candel Therapeutics

    Malignant Pleural Effusion

    phase 1 mab completed

    1 trial

  8. Adjuvant/Excipients

    Takeda

    Norovirus

    phase 1 small molecule completed

    1 trial

  9. An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachment inhibitor to an integrase inhibitor-based antiretroviral therapy regimen in adults living with HIV (ENTRANCE)

    ViiV Healthcare Pty Ltd

    HIV Infections

    phase 1 other active

    1 trial

  10. An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Maribavir Tablets 200 mg, manufactured by Sun Pharmaceutical Industries Limited, India with LIVTENCITY® (Maribavir) Coated Tablets 200 mg, manufactured by: Catalent CTS, LLC Kansas City, United States of America, packed by: Takeda Ireland Limited Bray, Ireland, imported by: Takeda Pharma Ltda. Highway SP 340 S/N, km 133.5 Jaguariúna Administrative Building -SP CNPJ 60.397.775/

    Lacuna Pharma Pty Ltd

    cytomegalovirus (CMV) infection and/or disease that is refractory (with or without resistance) to one or more prior therapies in adult patients who have undergone hematopoietic stem cell transplantation (HSCT) or solid organ transplantation (SOT)

    phase 1 other active

    1 trial

  11. BCX4430

    Biocryst

    Filovirus Infections

    phase 1 small molecule completed

    1 trial

  12. Bemnifosbuvir (BEM)

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    2 trials

  13. Bemnifosbuvir (BEM)

    Atea Pharmaceuticals

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  14. Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditions

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  15. Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combination

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule active

    1 trial

  16. CAN-2409 + valacyclovir

    Candel Therapeutics

    Lung Cancer

    phase 1 mab completed

    1 trial

  17. CD19/CD20 Dual-Target in vivo CAR-T Lentiviral product

    Nanjing Legend Biotech Co.

    Relapsed/Refractory B-cell Malignancies

    phase 1 mab active

    1 trial

  18. CERE-110: Adeno-Associated Virus Delivery of NGF

    SANGAMO THERAPEUTICS, INC

    Alzheimer's Disease

    phase 1 gene therapy completed

    1 trial

  19. CSL760

    CSL Behring GmbH

    Coronavirus Disease 2019 (COVID-19)

    phase 1 mab terminated

    1 trial

  20. Cohort 1 BEM + Ruzasvir

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  21. Cohort 1: Days 1-7 Bemnifosbuvir (BEM)/Ruzasvir (RZR) co-administered. Days 8-17 Bemnifosbuvir (BEM)/Ruzasvir (RZR) co-administered + Biktarvy (BIK). Days 18-24 BIK

    Atea Pharmaceuticals

    Healthy Volunteer Study

    phase 1 small molecule completed

    1 trial

  22. DEB025

    ENANTA PHARMACEUTICALS INC

    Hepatitis C Virus

    phase 1 small molecule completed

    1 trial

  23. Digoxin

    Takeda

    Cytomegalovirus (CMV)

    phase 1 small molecule completed

    1 trial

  24. EDP-721

    ENANTA PHARMACEUTICALS INC

    Chronic Hepatitis B Virus Infection

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources